News

When researchers analyzed the group of patients who only met the CT criteria for suspected bronchiectasis, they found that those with normal spirometry (n = 731) showed a lower difference in 10 ...
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for brensocatib for patients with non-cystic fibrosis bronchiectasis. Bronchiectasis is a ...
The time to first bronchiectasis exacerbation was significantly longer in the brensocatib-treated patients compared with those in the placebo group (10 mg treatment hazard ratio [HR] 0.58, 95% CI ...
Session ID: 2025-06-16:7c54e923d7ee1e0c5453a5ff Player Element ID: vjs_video_3 ...
Session ID: 2025-07-28:438ebd2caae66a0797e3fc0 Player Element ID: vjs_video_3 ...
LOS ANGELES — For patients with non–cystic fibrosis bronchiectasis, an investigational inhaled powder form of ciprofloxacin can significantly reduce the frequency of exacerbations, results ...